Racial differences in odds of asthma exacerbations among Aspergillus fumigatus-sensitized adults with asthma

Patrick K Gleeson1, Knashawn H Morales2, Meeta Prasad Kerlin3

  • 1Section of Allergy and Immunology, Division of Pulmonary, Allergy, and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Abstract

Insights

Black men show higher mold sensitization, a risk factor for asthma exacerbations. Aspergillus fumigatus allergy specifically impacts asthma outcomes in Black patients, contributing to health disparities.

Area of Science:

  • Environmental health
  • Allergy and immunology
  • Pulmonary medicine

Background:

  • Allergic sensitization to molds is a known risk factor for severe asthma.
  • Existing research has not adequately explored if mold allergy contributes to racial disparities in asthma outcomes.

Purpose of the Study:

  • To identify factors linked to mold sensitization.
  • To assess the association between mold sensitization and asthma exacerbations, stratified by race.

Main Methods:

  • Retrospective cohort study of 2732 adult asthma patients with aeroallergen testing.
  • Logistic regression models used to analyze factors associated with mold sensitization and its impact on asthma exacerbations.

Main Results:

  • Black race and male sex were significantly associated with increased mold sensitization.
  • Overall, mold sensitization did not correlate with asthma exacerbations.
  • Among Black patients, Aspergillus fumigatus sensitization was linked to higher odds of asthma exacerbations.

Conclusions:

  • Male sex and Black race are risk factors for mold sensitization.
  • Aspergillus fumigatus allergy may be a key driver of racial disparities in asthma exacerbations.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
371
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246